Chemotherapy and EGFR tyrosine kinase inhibitors for treatment of brain metastases from non-small-cell lung cancer: survival analysis in 210 patients
Y Fan, Z Huang, L Fang, L Miu, N Lin… - OncoTargets and …, 2013 - Taylor & Francis
Background Chemotherapy and epidermal growth factor receptor (EGFR) tyrosine kinase
inhibitors are controversial in the treatment of patients with brain metastases from non-small …
inhibitors are controversial in the treatment of patients with brain metastases from non-small …
Chemotherapy and EGFR tyrosine kinase inhibitors for treatment of brain metastases from non-small-cell lung cancer: survival analysis in 210 patients
Y Fan, Z Huang, F Luo, L Miu, N Lin… - OncoTargets and …, 2013 - search.proquest.com
Background: Chemotherapy and epidermal growth factor receptor (EGFR) tyrosine kinase
inhibitors are controversial in the treatment of patients with brain metastases from non-small …
inhibitors are controversial in the treatment of patients with brain metastases from non-small …
Chemotherapy and EGFR tyrosine kinase inhibitors for treatment of brain metastases from non-small-cell lung cancer: survival analysis in 210 patients
Y Fan, Z Huang, L Fang, L Miu, N Lin, L Gong… - OncoTargets and …, 2013 - go.gale.com
Background: Chemotherapy and epidermal growth factor receptor (EGFR) tyrosine kinase
inhibitors are controversial in the treatment of patients with brain metastases from non …
inhibitors are controversial in the treatment of patients with brain metastases from non …
[HTML][HTML] Chemotherapy and EGFR tyrosine kinase inhibitors for treatment of brain metastases from non-small-cell lung cancer: survival analysis in 210 patients
Y Fan, Z Huang, L Fang, L Miu, N Lin… - OncoTargets and …, 2013 - ncbi.nlm.nih.gov
Background Chemotherapy and epidermal growth factor receptor (EGFR) tyrosine kinase
inhibitors are controversial in the treatment of patients with brain metastases from non-small …
inhibitors are controversial in the treatment of patients with brain metastases from non-small …
Chemotherapy and EGFR tyrosine kinase inhibitors for treatment of brain metastases from non-small-cell lung cancer: survival analysis in 210 patients
Y Fan, Z Huang, L Fang, L Miu, N Lin… - OncoTargets and …, 2013 - pubmed.ncbi.nlm.nih.gov
Background Chemotherapy and epidermal growth factor receptor (EGFR) tyrosine kinase
inhibitors are controversial in the treatment of patients with brain metastases from non-small …
inhibitors are controversial in the treatment of patients with brain metastases from non-small …
Chemotherapy and EGFR tyrosine kinase inhibitors for treatment of brain metastases from non-small-cell lung cancer: survival analysis in 210 patients.
Y Fan, Z Huang, L Fang, L Miu, N Lin… - OncoTargets & …, 2013 - search.ebscohost.com
Background: Chemotherapy and epidermal growth factor receptor (EGFR) tyrosine kinase
inhibitors are controversial in the treatment of patients with brain metastases from non …
inhibitors are controversial in the treatment of patients with brain metastases from non …
[引用][C] Chemotherapy and EGFR tyrosine kinase inhibitors for treatment of brain metastases from non-small-cell lung cancer: survival analysis in 210 patients.
Y Fan, Z Huang, L Fang, L Miu, N Lin… - OncoTargets and …, 2013 - scholarmate.com
BACKGROUND: Chemotherapy and epidermal growth factor receptor (EGFR) tyrosine
kinase inhibitors are controversial in the treatment of patients with brain metastases from …
kinase inhibitors are controversial in the treatment of patients with brain metastases from …
Chemotherapy and EGFR tyrosine kinase inhibitors for treatment of brain metastases from non-small-cell lung cancer: survival analysis in 210 patients.
Y Fan, Z Huang, L Fang, L Miu, N Lin… - Oncotargets and …, 2013 - europepmc.org
Background Chemotherapy and epidermal growth factor receptor (EGFR) tyrosine kinase
inhibitors are controversial in the treatment of patients with brain metastases from non-small …
inhibitors are controversial in the treatment of patients with brain metastases from non-small …
[PDF][PDF] chemotherapy and egFr tyrosine kinase inhibitors for treatment of brain metastases from non-small-cell lung cancer: survival analysis in 210 patients
Y Fan, W Mao - OncoTargets and Therapy, 2013 - pdfs.semanticscholar.org
Background: Chemotherapy and epidermal growth factor receptor (EGFR) tyrosine kinase
inhibitors are controversial in the treatment of patients with brain metastases from non …
inhibitors are controversial in the treatment of patients with brain metastases from non …
[PDF][PDF] chemotherapy and egFr tyrosine kinase inhibitors for treatment of brain metastases from non-small-cell lung cancer: survival analysis in 210 patients
Y Fan, W Mao - OncoTargets and Therapy, 2013 - Citeseer
Background: Chemotherapy and epidermal growth factor receptor (EGFR) tyrosine kinase
inhibitors are controversial in the treatment of patients with brain metastases from non …
inhibitors are controversial in the treatment of patients with brain metastases from non …